Depression and risk of mortality in individuals with diabetes: A meta-analysis and systematic review

General Hospital Psychiatry

Volumn 35, Issue 3, 2013, Pages 217-225

  Park, Mijung ^a   Katon, Wayne J ^b   Wolf, Fredric M ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Diabetes mellitus; Meta analysis; Mortality; Systematic review

Indexed keywords

ANTIDEPRESSANT AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; EFFECT SIZE; HAZARD RATIO; HUMAN; LONGITUDINAL STUDY; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; REGRESSION ANALYSIS; SYSTEMATIC REVIEW; VALIDITY;

COMORBIDITY; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; RISK FACTORS;

EID: 84876965357     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2013.01.006     Document Type: Article

References (69)

1. Kessler R.C., et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62(6):593-602.
2. Centers for Disease Control, and Prevention National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States 2011, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
3. Anderson R.J., et al. The prevalence of comorbid depression in adults with diabetes. Diabetes Care 2001, 24(6):1069-1078.
4. Li C., et al. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 Behavioral Risk Factor Surveillance System. Diabetes Care 2008, 31:105.
5. Ali S., et al. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2006, 23(11):1165-1173.
6. Ludman E.J., et al. Depression and diabetes symptom burden. Gen Hosp Psychiatry 2004, 26(6):430-436.
7. Gonzalez J.S., et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 2008, 31(12):2398-2403.
8. Egede L.E., Zheng D., Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002, 25(3):464-470.
9. Symons M.J., Moore D.T. Hazard rate ratio and prospective epidemiological studies. J Clin Epidemiol 2002, 55(9):893-899.
10. Altman D.G., Bland J.M. Interaction revisited: the difference between two estimates. BMJ 2003, 326(7382):219.
11. Grote N.K., et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010, 67(10):1012-1024.
12. The Nordic Cochrane Centre Review Manager 2008, The Cochrane Collaboration, Copenhagen.
13. Borenstein M., et al. Comprehensive meta-analysis: a computer program for meta-analysis 2007, Biostat Inc., Englewood, NJ.
14. Rosenthal R., DiMatteo M.R. Meta analysis: recent developments in quantitative methods for literature reviews. Annu Rev Psychol 2001, 52:59-82.
15. Parmar M.K.B., Torri V., Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17(24):2815-2834.
16. Freels S. Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints. Stat Med 2004, 23(11):1817.
17. Spruance S.L., et al. Hazard ratio in clinical trials. Antimicrob Agents Chemother 2004, 48(8):2787-2792.
18. Michiels S., et al. Meta-analysis when only the median survival times are known: a comparison with individual patient data results. Int J Technol Assess Health Care 2005, 21(01):119-125.
19. Lewis S., Clarke M. Forest plots: trying to see the wood and the trees. BMJ 2001, 322(7300):1479-1480.
20. Higgins J.P.T., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558.
21. Higgins J.P.T., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
22. Thompson S.G., Higgins J.P.T. How should meta-regression analyses be undertaken and interpreted?. Stat Med 2002, 21(11):1559-1573.
23. Wallace B., et al. Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 2009, 9(1):80.
24. Egger M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634.
25. Sterne J.A.C., Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001, 54(10):1046-1055.
26. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56(2):455-463.
27. Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull 1979, 86(3):638-641.
28. Black S.A., Markides K.S., Ray L.A. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003, 26(10):2822-2828.
29. Zhang X., et al. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 2005, 161(7):652-660.
30. Bruce D.G., et al. A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 2005, 48(12):2532-2539.
31. Richardson L.K., Egede L.E., Mueller M. Effect of race/ethnicity and persistent recognition of depression on mortality in elderly men with type 2 diabetes and depression. Diabetes Care 2008, 31(5):880-881.
32. Katon W., et al. Depression and diabetes: a potentially lethal combination. J Gen Intern Med 2008, 23(10):1571-1575.
33. Lin E.H.B., et al. Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med 2009, 7(5):414-421.
34. Pan A., et al. Increased mortality risk in women with depression and diabetes mellitus. Arch Gen Psychiatry 2011, 68(1):42-50.
35. Sullivan M.D., et al. Depression predicts all-cause mortality. Diabetes Care 2012, 35(8):1708-1715.
36. Ahola A., et al. Purchase of antidepressant agents by patients with type 1 diabetes is associated with increased mortality rates in women but not in men. Diabetologia 2012, 55(1):73-79.
37. Pieper L., et al. Longitudinale Assoziationen zwischen depressiven Symptomen und Typ-2-Diabetes sowie deren Auswirkung auf die Mortalität von Hausarztpatienten. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2011, 54(1):98-107.
38. Ismail K., et al. A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality. Diabetes Care 2007, 30(6):1473-1479.
39. Bot M., et al. Association of coexisting diabetes and depression with mortality after myocardial infarction. Diabetes Care 2012, 35(3):503-509.
40. Katon W.J., et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005, 28(11):2668-2672.
41. Egede L.E., Nietert P.J., Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005, 28(6):1339-1345.
42. Lee T., et al. Mortality rate in veterans with multiple chronic conditions. J Gen Intern Med 2007, 22:403-407.
43. Rosenthal M.J., et al. Hospitalization and mortality of diabetes in older adults: a 3-year prospective study. Diabetes Care 1998, 21(2):231-235.
44. Black S.A., Markides K.S. Depressive symptoms and mortality in older Mexican Americans. Ann Epidemiol 1999, 9(1):45-52.
45. Prisciandaro J.J., et al. Impact of psychiatric comorbidity on mortality in veterans with type 2 diabetes. Diabetes Technol Ther 2011, 13(1):73-78.
46. Reynolds S.L., Haley W.E., Kozlenko N. The impact of depressive symptoms and chronic diseases on active life expectancy in older Americans. Am J Geriatr Psychiatry 2008, 16(5):425-432. 10.1097/JGP.0b013e31816ff32e.
47. Gallo J.J., et al. Depression, cardiovascular disease, diabetes, and two-year mortality among older, primary-care patients. Am J Geriatr Psychiatry 2005, 13(9):748-755.
48. Bogner H.R., et al. Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care 2007, 30(12):3005-3010.
49. Landman G.W.D., et al. Health-related quality of life and mortality in a general and elderly population of patients with type 2 diabetes (ZODIAC-18). Diabetes Care 2010, 33(11):2378-2382.
50. Milano A., Singer R. Mortality in co-morbidity (II)-excess death rates derived from a follow-up study on 10,025 subjects divided into 4 groups with or without depression and diabetes mellitus. J Insur Med 2007, 39(3):160-166.
51. Stroup D.F., et al. Meta-analysis of observational studies in epidemiology. JAMA 2000, 283(15):2008-2012.
52. Carson K.P., Schriesheim C.A., Kinicki A.J. The usefulness of the "fail-safe" statistic in meta-analysis. Educ Psychol Meas 1990, 50(2):233-243.
53. Barth J., Schumacher M., Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004, 66(6):802-813.
54. Katon W.J. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003, 54(3):216-226.
55. Golden S., et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008, 299:2751.
56. Stuart M.J., Baune B.T. Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci Biobehav Rev 2012, 36(1):658-676.
57. Silva N., Atlantis E., Ismail K. A review of the association between depression and insulin resistance: pitfalls of secondary analyses or a promising new approach to prevention of type 2 diabetes?. Curr Psychiatry Rep 2012, 14(1):8-14.
58. de Groot M., et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001, 63(4):619-630.
59. Katon W., Lyles C.R., Parker M.M., Karter A.J., Huang E.S., Whitmer R.A. Association of depression with increased risk of dementia in patients with type 2 diabetes: the diabetes and aging study. Arch Gen Psychiatry 2012, 69(4):410-417.
60. Pan A., et al. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 2011, 306(11):1241-1249.
61. Pinquart M., Duberstein P.R. Depression and cancer mortality: a meta-analysis. Psychol Med 2010, 40(11):1797-1810.
62. de Voogd J.N., et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest 2009, 135(3):619-625.
63. Cuijpers P., Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 2002, 72(3):227-236.
64. Akincigil A., et al. Racial and ethnic disparities in depression care in community-dwelling elderly in the United States. Am J Public Health 2011, 102(2):319-328.
65. Bhugra D., Jones P. Migration and mental illness. Adv Psychiatr Treat 2001, 7(3):216-222.
66. McBean A.M., et al. Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, Hispanics, and Asians. Diabetes Care 2004, 27(10):2317-2324.
67. Katon W., et al. The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004, 61(10):1042-1049.
68. Ell K., et al. Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial. Diabetes Care 2010, 33(4):706-713.
69. Williams J.W., et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004, 140(12):1015-1024.